Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for secondary packaging, control/testing of batch, batch release authorization)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Dosage form: capsules
Active substance Dosage temozolomide 5 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or after radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Dosage form: capsules
Active substance Dosage temozolomide 100 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Dosage form: capsules
Active substance Dosage temozolomide 140 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Dosage form: capsules
Active substance Dosage temozolomide 180 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in the form of glioblastoma multiforme or anaplastic astrocytoma, if the disease progresses or recurs after standard treatment.
Dosage form: capsules
Active substance Dosage temozolomide 20 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with or following radiotherapy), as well as for children from 3 years of age and adults with malignant glioma in cases of disease recurrence or progression.
Dosage form: capsules
Active substance Dosage temozolomide 250 mg ATC: L01AX03